Skip to content

Critical Reviews in Toxicology

ISSN 1547-6898

3 papers in the library · 60 citations · publishing 2012-2023

Papers

Sort Most recent Most cited

25X-NBOMe compounds - chemistry, pharmacology and toxicology. A comprehensive review.

Critical Reviews in Toxicology 2023 Monika Herian, Paweł Świt 9 citations

Recently, a growing number of reports have indicated a positive effect of hallucinogenic-based therapies in different neuropsychiatric disorders. However, hallucinogens belonging to the group of new psychoactive substances (NPS) may produce high toxicity. NPS, due to their multi-receptors affinity, are extremely dangerous for the human body and mental health. An example of hallucinogens that...

The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review

Critical Reviews in Toxicology May 27, 2020 Vera L Alves, João L Gonçalves, Joselin Aguiar et al.

Abstract The word “cannabinoid” refers to every chemical substance, regardless of structure or origin, that joins the cannabinoid receptors of the body and brain and that have similar effects to those produced by the Cannabis plant and based on their source of production, cannabinoids can be classified into endocannabinoids, phytocannabinoids and synthetic cannabinoids. Synthetic cannabinoids...

Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug–drug interactions

Critical Reviews in Toxicology October 3, 2012 Saskia J. Rietjens, Laura Hondebrink, Remco H S Westerink et al. 51 citations

Clinical outcome following 3,4-methylenedioxymethamphetamine (MDMA) intake ranges from mild entactogenic effects to a life-threatening intoxication. Despite ongoing research, the clinically most relevant mechanisms causing acute MDMA-induced adverse effects remain largely unclear. This complicates the triage and treatment of MDMA users needing medical care. The user's genetic profile and...